Abstract:Both reversible noncovalent inhibitors and irreversible covalent inhibitors targeting tyrosine kinases have their disadvantages. The reversible covalent inhibitors with electrophilic group cyanoacrylamide as warheads reacting with cysteine residues could solve the dilemmas. However, there are still several unresolved issues regarding the electrophilic groups. In this manuscript, a series of EGFR inhibitors with double electron-withdrawing substituents introduced into the C-alpha position on the olefin bond were designed and synthesized. The binding structures and characteristics of inhibitors with the kinase in both the first noncovalent binding phase and the second covalent binding step were explored and combined with molecular docking and molecular dynamics simulations. Then, the reverse beta-elimination reactions of the thiol-Michael adducts were investigated by applying density functional theory calculations. In addition, the effects of different electrophilic substituents of C-alpha on the binding between the inhibitors and kinase were elucidated. The results suggested that the electrophilicity and size of the electron-withdrawing groups play an important role in the specific interactions during the reaction. The compounds with the electron-withdrawing groups that had medium electrostatic and steric complementarity to the kinase active site could cooperatively stabilize the complexes and showed relatively good potent activities in the kinase assay experiment. The mechanical and structural information in this study could enhance our understanding of the functioning of the electron-withdrawing groups in the covalent inhibitors. The results might help to design efficient cysteine targeting inhibitors in the future.

Crystal structure of triple-BRCT-domain of ECT2 and insights into the binding characteristics to CYK-4.

Functional Study Of Cbs Domain Interaction During Common Gating Of Clc-0 Chloride Channel

NMR study of the structure and dynamics of the BRCT domain from the kinetochore protein KKT4

Molecular Basis for Control of Diverse Genome Stability Factors by the Multi-BRCT Scaffold Rtt107.

Discovery and Computational Studies of Potent Covalent Kinase Inhibitors with -Substituent Electrophiles Targeting Cysteine

Conformational heterogeneity of the BTK PHTH domain drives multiple regulatory states

Pentameric Assembly of the Kv2.1 Tetramerization Domain

Discovery and Computational Studies of Potent Covalent Kinase Inhibitors with alpha-Substituent Electrophiles Targeting Cysteine

Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation.

Structural Insights into the Interaction Between CRTCs and 14-3-3

Crystal Structure and Functional Analysis of the Eukaryotic Class II Release Factor Erf3 from S. Pombe

Selective inhibition reveals the regulatory function of DYRK2 in protein synthesis and calcium entry

Crystallization and Preliminary X-ray Crystallographic Analysis of the Human CKIP-1 Pleckstrin Homology Domain.

Crystal Structure of Human ASB9-2 and Substrate-Recognition of CKB

Crystal Structure and Biochemical Analyses Reveal Beclin 1 As a Novel Membrane Binding Protein

Structure and regulation of human epithelial cell transforming 2 protein.

Crystallization And Preliminary Crystallographic Studies Of The Single-Chain Variable Fragment Of Antibody Cha21 In Complex With An N-Terminal Fragment Of Erbb2

Crystal structures reveal a novel dimer of the RWD domain of human general control nonderepressible 2

Elucidating TH301's influence on the torsion angle of CRY1 W399 using replica exchange with solute tempering (REST) molecular dynamics (MD) simulations

Structural insights revealed by the cocrystal structure of CCS1477 in complex with CBP bromodomain

The co-crystal structure of Cbl-b and a small-molecule inhibitor reveals the mechanism of Cbl-b inhibition